CIK: 0001683689 · Show all filings
Period: Q1 2022 (← Previous) (Next →)
Filing Date: May 16, 2022
Total Value ($000): $185,051 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | Horizon Therapeutics Public Limited Company | 544,835 | $57,322 | 31.0% | $68.27 | — | SHS | G46188101 |
| IEFA | ISHARES TR | 380,847 | $26,473 | 14.3% | $73.23 | — | CORE MSCI EAFE | 46432F842 |
| — | JAMF HOLDING CORP | 614,410 | $21,388 | 11.6% | $36.02 | — | COM | 47074L105 |
| VCEL | Vericel Corporation | 552,925 | $21,133 | 11.4% | $15.89 | +127.1% | COM | 92346J108 |
| NEO | NeoGenomics Inc. | 1,614,263 | $19,613 | 10.6% | $23.81 | -11.6% | COM NEW | 64049M209 |
| FIVN | Five9, Inc. | 166,310 | $18,361 | 9.9% | $121.16 | -3.9% | COM | 338307101 |
| IEMG | ISHARES TR | 304,825 | $16,933 | 9.2% | $64.35 | — | CORE MSCI EMKT | 46434G103 |
| MITK | MITEK SYS INC | 237,128 | $3,479 | 1.9% | $18.84 | -18.7% | COM NEW | 606710200 |
| ISTB | ISHARES TR | 2,228 | $108 | 0.1% | $51.59 | — | CORE 1 5 YR USD | 46432F859 |
| IVV | ISHARES TR | 234 | $106 | 0.1% | $335.62 | — | CORE S&P500 ETF | 464287200 |
| IAGG | ISHARES TR | 862 | $45 | 0.0% | $56.04 | — | CORE INTL AGGR | 46435G672 |
| IMTB | ISHARES TR | 834 | $39 | 0.0% | $52.19 | — | CR 5 10 YR ETF | 46435G417 |
| IJH | ISHARES TR | 122 | $33 | 0.0% | $183.67 | — | CORE S&P MCP ETF | 464287507 |
| IJR | ISHARES TR | 169 | $18 | 0.0% | $72.46 | — | CORE S&P SCP ETF | 464287804 |